| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.22 | 0.2 |